Lung Cancer
RASolve 301: Phase 3 Multicenter, Open Label, Randomized Study of RMC-6236 versus Docetaxel in Patients with Previously Treated Locally Advanced or Metastatic RAS[MUT]NSCLC (RMC-6236-301)
- Details
ClinicalTrials.gov ID:
NCT06881784
Diagnosis Type:
NA
USOR Number:
- Address
,
P: